Insulet Corporation (PODD)

Sector: Healthcare|Industry: Medical Devices|Market Cap: $18.68B|Employees: 3K

Insulet Corporation is a medical device company focused on the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. Their Omnipod platform is a tubeless system that eliminates the need for injections and tubing, offering a unique approach to insulin management. The company's key markets include the United States, Europe, Canada, and Australia, with a growing global presence.